-
effectivehealthcare.ahrq.gov/products/lysosomal-storage-diseases-therapies/technical-brief
January 02, 2013 - The purpose of a Technical Brief is to report what outcomes (benefits and harms) have been studied for … comparative effectiveness review or systematic review that draws conclusions as to the clinical benefits and harms … Harms reported to the FDA and in clinical studies were primarily allergic, including infusion-associated
-
effectivehealthcare.ahrq.gov/products/traumatic-brain-injury-rehabilitation/research
June 20, 2012 - evaluate evidence on participation outcomes of productivity and community integration and treatment harms … One study addressed harms and found no treatment-related harms.
-
effectivehealthcare.ahrq.gov/products/dietary-supplements/research
April 30, 2012 - Objectives
For supplements commonly used by patients with cardiovascular disease, we examined benefits, harms … Evidence was insufficient for all gradable clinical efficacy and harms outcomes (e.g., mortality, thrombotic … Evidence regarding harms was inconclusive.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
June 01, 2013 - Also, because the majority of evidence on noncontraceptive
benefits and harms of OC use is derived from … 3
KQ 5: What are the harms of OC use, including
breast cancer incidence, cervical cancer incidence … How do these harms vary by dose or
formulation, duration of use, or specific population? … KQ 6: Based on the comprehensive literature review,
what are the benefits and harms from the use of … For incident harms and benefits, the
likelihood that benefits outweighed harms was less than
40 percent
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharm-treatment-chronic-pain-protocol.pdf
December 11, 2018 - What are the benefits and harms of noninvasive nonpharmacologic
therapies compared with exercise? … What are the benefits and harms of noninvasive nonpharmacologic
therapies compared with exercise? … What are the benefits and harms of noninvasive nonpharmacologic
therapies compared with exercise? … What are the benefits and harms of noninvasive nonpharmacologic
therapies compared with exercise? … What are the benefits and harms of noninvasive nonpharmacologic
therapies compared with biofeedback?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-bias-individual-studies_methods.pdf
March 01, 2012 - Assessing the Risk of Bias for Harms
Although the assessment of harms is almost always included as an … Although reviewers recognize the importance of harms outcomes, harms are
generally ignored in risk-of-bias … The McMaster University Harms scale (McHarm) was developed specifically for evaluating
harms and is … Was the mode of harms collection specified as ACTIVE?
6. … Did the study specify WHO collected the harms?
8.
-
effectivehealthcare.ahrq.gov/products/breast-cancer-medications/research
September 14, 2009 - raloxifene, and tibolone to reduce risk for primary breast cancer, assess the nature and magnitude of harms … , and examine how benefits and harms vary by age, breast cancer risk status, and other factors.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-259-partial-breast-irradiation-executive-summary.pdf
January 01, 2023 - This systematic review assesses the comparative effectiveness and harms of PBI
compared with WBI for … cm that has minimal or no lymph node involvement (N0/1), and how
differences in effectiveness and harms … Comparative Effectiveness and Harms of PBI Versus
WBI
Thirteen RCTs reported in 38 articles with a … total of 15,276 patients were included in
the assessment of the comparative effectiveness and harms … of PBI Versus WBI
Comparative Effectiveness and Harms of PBI Modalities
Financial Toxicity Related
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/urinary-incontinence-update_research-protocol.pdf
June 06, 2017 - What are the harms from nonpharmacological treatments when compared with no
active treatment? … What are the comparative harms from nonpharmacological treatments when
compared with each other? … What are the harms from pharmacological treatments when compared with no
active treatment?
2c. … What are the comparative harms from pharmacological treatments when
compared with each other? … KQ 4:
What are the benefits and harms of combined nonpharmacological and
pharmacological treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/moyer_eccs2012.pdf
January 01, 2012 - studies, but reviews and
assesses existing
research
o Evaluates the balance of benefits and harms … when the evidence is insufficient in quality or
quantity
Slide 4: Balance
of Benefits
and Harms … Benefits – Harms = Net Benefit
Source: Eisenberg Center Conference Series 2012: Supporting
Informed … There is moderate or
hig certainty
that the
service has no net benefit or that the harms
outweigh … USPSTF concludes
that current evidence is insufficient to
assess
the balance of benefits and harms
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-effectiveness-and-harms-of-treatments-for-traumatic-brain-injury-preliminary-key-questions-1-what-is-the-comparative-effectiveness-of-the-treatments-for-tbi-for-grades-i-iv-2-for-patients-what-are-the-
December 07, 2009 - What is the comparative effectiveness and harms of treatments for traumatic brain injury? … For patients, what are the potential harms of TBI treatment interventions? … quality of life, hospitalizations/ER visits
Describe any health-related risks, side effects, or harms … Evidence regarding effectiveness and harms of treatments, or information regarding the lack of evidence
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_executive.pdf
September 01, 2014 - How are patient factors related to the harms of
different imaging techniques?
b. … For KQ3 on the rates of procedural harms, we included
any reported harms data based on 50 or more patients … – For harms (KQ3), this means a statement appearing
in the Methods section that harms/complications … We did not grade the strength of evidence for
harms. … ,
the harms of concern are different for different tests.
-
effectivehealthcare.ahrq.gov/products/long-term-care-adults/research
November 07, 2012 - trajectories for physical function, cognition, mental health, mortality, use of acute care services, harms … HCBS with NHs, low-strength evidence suggested that HCBS recipients experienced higher rates of some harms … while NH residents experienced higher rates of other harms.
-
effectivehealthcare.ahrq.gov/products/mrsa-screening-2010/research
June 20, 2013 - Structured Abstract
Objectives
To synthesize comparative studies that examined the benefits and harms … insufficient evidence on other outcomes of universal MRSA screening, including morbidity, mortality, harms … screening and infection control interventions and address outcomes, including morbidity, mortality, harms
-
effectivehealthcare.ahrq.gov/products/trauma-child-interventions/research
February 11, 2013 - subgroup characteristics that moderate the effect of an intervention on outcomes (KQ 3); and to assess harms … We also found almost no evidence on harms associated with psychological treatments. … Only pharmacological interventions attempted to assess harms in this vulnerable population.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-treatment-ssri_surveillance.pdf
January 01, 2013 - This trial had low risk
of bias, and harms were well monitored and
reported. … How do the harms
compare across different interventions? … Harms for interventions for both adults and
adolescents were predominately derived from
RCTs. … This trial had low
risk of bias, and harms were well monitored
and reported. … How do the harms compare across
different interventions?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_executive.pdf
July 01, 2014 - must be balanced against the potential harms to
mother and fetus of untreated depression. … Objectives
The objective of this systematic review was to evaluate
the benefits and harms of various … What are the comparative harms of
pharmacological and nonpharmacological treatments
for women with … Child Harms
Evidence on harms to the child of a mother treated
for depression during pregnancy was limited … These studies contributed
to the evidence on potential harms with treatment during
pregnancy.
-
effectivehealthcare.ahrq.gov/products/headaches-pregnancy/protocol
November 12, 2019 - Specifically, the review will address: (1) the (comparative) benefits and harms of pharmacologic and … For harms, we will also search the U.S. … For harms, we will also search the U.S. … We expect to summarize harms data semi-quantitatively (i.e., without meta-analysis). … We expect to primarily rely on reported within-study differences in effects (or harms).
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/headaches-pregnancy.pdf
March 23, 2019 - Specifically, the review will address: (1) the
(comparative) benefits and harms of pharmacologic and … o For harms, we will also search the U.S. … o For harms, we will also search the U.S. … We expect to summarize harms
data semi-quantitatively (i.e., without meta-analysis). … We expect to primarily rely on reported within-study
differences in effects (or harms).
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ocr-protocol-final_1.pdf
December 18, 2019 - 1a: How do effectiveness and harms vary by choice of prostaglandin? … • Include high quality
cohort and case-control
studies for harms. … • Include high quality
cohort and case-
control studies for
harms. … • Include high quality
cohort and case-
control studies for
harms. … • Include high quality
cohort and case-control
studies for harms.